X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DM | 2024-02-07 | EWTX | Moore John R | GC | S - Sale+OE | $20.00 | -29,835 | 0 | -100% | -$596,805 | |||||
DM | 2024-02-07 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $20.03 | -10,000 | 7,020 | -59% | -$200,258 | |||||
D | 2024-01-23 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $15.78 | -90,000 | 29,024 | -76% | -$1,419,759 | |||||
2024-01-23 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $11.00 | +454,545 | 14,756,096 | +3% | +$4,999,995 | ||||||
2024-01-23 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $11.00 | +454,545 | 14,756,096 | +3% | +$4,999,995 | ||||||
2023-12-26 | EWTX | Fox Jonathan C | Dir | P - Purchase | $9.30 | +10,857 | 10,857 | New | +$100,958 | ||||||
2023-12-27 | EWTX | Moore John R | GC | S - Sale | $10.50 | -8,497 | 0 | -100% | -$89,219 | ||||||
2023-12-26 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $9.33 | -172,585 | 3,606 | -98% | -$1,610,097 | ||||||
D | 2023-05-02 | EWTX | Derakhshan Behrad | Chief Business Officer | S - Sale+OE | $8.90 | -1,747 | 7,020 | -20% | -$15,557 | |||||
D | 2023-05-02 | EWTX | Moore John R | GC | S - Sale+OE | $8.90 | -1,897 | 6,565 | -22% | -$16,893 | |||||
D | 2023-05-02 | EWTX | Carruthers R Michael | CFO | S - Sale+OE | $8.90 | -1,336 | 16,126 | -8% | -$11,897 | |||||
D | 2023-05-02 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale+OE | $8.90 | -1,602 | 176,191 | -1% | -$14,266 | |||||
D | 2023-05-02 | EWTX | Donovan Joanne M. | CMO | S - Sale+OE | $8.90 | -3,254 | 9,960 | -25% | -$28,977 | |||||
D | 2023-05-02 | EWTX | Koch Kevin | Pres, CEO | S - Sale+OE | $8.90 | -3,203 | 345,997 | -1% | -$28,522 | |||||
D | 2022-10-03 | EWTX | Moore John R | GC | S - Sale+OE | $9.76 | -4,730 | 3,000 | -61% | -$46,155 | |||||
2022-09-16 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $10.32 | +484,496 | 14,301,551 | +4% | +$4,999,999 | ||||||
2022-09-16 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $10.32 | +484,496 | 14,301,551 | +4% | +$4,999,999 | ||||||
2022-09-14 | EWTX | Novo Holdings A/s | 10% | P - Purchase | $10.32 | +484,496 | 6,071,703 | +9% | +$4,999,999 | ||||||
D | 2022-09-06 | EWTX | Moore John R | GC | S - Sale+OE | $10.91 | -4,730 | 3,000 | -61% | -$51,598 | |||||
D | 2022-08-03 | EWTX | Moore John R | GC | S - Sale+OE | $9.31 | -9,232 | 3,000 | -75% | -$85,921 | |||||
DM | 2022-07-05 | EWTX | Moore John R | GC | S - Sale+OE | $8.37 | -9,232 | 3,000 | -75% | -$77,256 | |||||
DM | 2022-06-16 | EWTX | Moore John R | GC | S - Sale+OE | $6.83 | -67,927 | 3,000 | -96% | -$463,935 | |||||
DM | 2022-06-13 | EWTX | Moore John R | GC | S - Sale+OE | $6.08 | -26,381 | 3,000 | -90% | -$160,457 | |||||
DM | 2022-06-08 | EWTX | Moore John R | GC | S - Sale+OE | $6.44 | -27,306 | 3,000 | -90% | -$175,878 | |||||
DM | 2022-06-03 | EWTX | Moore John R | GC | S - Sale+OE | $6.26 | -47,287 | 3,000 | -94% | -$295,985 | |||||
2022-05-18 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $7.21 | +138,000 | 13,817,055 | +1% | +$994,980 | ||||||
2022-05-18 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $7.21 | +138,000 | 13,817,055 | +1% | +$994,980 | ||||||
2022-05-16 | EWTX | Moore John R | GC | S - Sale | $7.42 | -10,800 | 3,000 | -78% | -$80,146 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |